Literature DB >> 19932736

Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro.

Gabriella Horvath1, Laszlo Mark, Reka Brubel, Peter Szakaly, Boglarka Racz, Peter Kiss, Andrea Tamas, Zsuzsanna Helyes, Andrea Lubics, Hitoshi Hashimoto, Akemichi Baba, Norihito Shintani, Gergely Furjes, Jozsef Nemeth, Dora Reglodi.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a multifunctional neuropeptide, showing widespread occurrence in the nervous system and also in peripheral organs. The neuroprotective effects of PACAP are well-established in different neuronal systems against noxious stimuli in vitro and in vivo. Recently, its general cytoprotective actions have been recognized, including renoprotective effects. However, the effect of endogenous PACAP in the kidneys is not known. The main aim of the present study was to investigate whether the lack of this endogenous neuropeptide influences survival of kidney cells against oxidative stress. First, we determined the presence of endogenous PACAP from mouse kidney homogenates by mass spectrometry and PACAP-like immunoreactivity by radioimmunoassay. Second, primary cultures were isolated from wild type and PACAP deficient mice and cell viability was assessed following oxidative stress induced by 0.5, 1.5 and 3mM H(2)O(2). Our mass spectrometry and radioimmunoassay results show that PACAP is endogenously present in the kidney. The main part of our study revealed that the sensitivity of cells from PACAP deficient mice was increased to oxidative stress: both after 2 or 4h of exposure, cell viability was significantly reduced compared to that from control wild type mice. This increased sensitivity of kidneys from PACAP deficient mice could be counteracted by exogenously given PACAP38. These results show, for the first time, that endogenous PACAP protects against oxidative stress in the kidney, and that PACAP may act as a stress sensor in renal cells. These findings further support the general cytoprotective nature of this neuropeptide. (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932736     DOI: 10.1016/j.neulet.2009.11.046

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells.

Authors:  Laszlo Mester; Krisztina Kovacs; Boglarka Racz; Izabella Solti; Tamas Atlasz; Krisztina Szabadfi; Andrea Tamas; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-07-20       Impact factor: 3.444

2.  Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells.

Authors:  Gabriella Horvath; Reka Brubel; Krisztina Kovacs; Dora Reglodi; Balazs Opper; Andrea Ferencz; Peter Szakaly; Eszter Laszlo; Lidia Hau; Peter Kiss; Andrea Tamas; Boglarka Racz
Journal:  J Mol Neurosci       Date:  2010-07-30       Impact factor: 3.444

3.  Regulation of oxidative stress by pituitary adenylate cyclase-activating polypeptide (PACAP) mediated by PACAP receptor.

Authors:  Hirokazu Ohtaki; Atsushi Satoh; Tomoya Nakamachi; Sachiko Yofu; Kenji Dohi; Hiroyoshi Mori; Kenji Ohara; Kazuyuki Miyamoto; Hitoshi Hashimoto; Norihito Shintani; Akemichi Baba; Masaji Matsunaga; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2010-04-13       Impact factor: 3.444

4.  Presence of endogenous PACAP-38 ameliorated intestinal cold preservation tissue injury.

Authors:  Andrea Ferencz; Gyorgy Weber; Zsuzsanna Helyes; Hitoshi Hashimoto; Akemichi Baba; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2010-04-09       Impact factor: 3.444

5.  Changes of PACAP immunoreactivities and cytokine levels after PACAP-38 containing intestinal preservation and autotransplantation.

Authors:  Klara Nedvig; Gyorgy Weber; Jozsef Nemeth; Krisztina Kovacs; Dora Reglodi; Agnes Kemeny; Andrea Ferencz
Journal:  J Mol Neurosci       Date:  2012-08-17       Impact factor: 3.444

6.  Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion.

Authors:  Gabriella Horvath; Boglarka Racz; Dora Reglodi; Krisztina Kovacs; Peter Kiss; Ferenc Gallyas; Zita Bognar; Aliz Szabo; Tamas Magyarlaki; Eszter Laszlo; Andrea Lubics; Andrea Tamas; Gabor Toth; Peter Szakaly
Journal:  J Mol Neurosci       Date:  2010-03-16       Impact factor: 3.444

Review 7.  VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.

Authors:  Terry W Moody; Tetsuhide Ito; Nuramy Osefo; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-02       Impact factor: 3.243

8.  PACAP is an endogenous protective factor-insights from PACAP-deficient mice.

Authors:  D Reglodi; P Kiss; K Szabadfi; T Atlasz; R Gabriel; G Horvath; P Szakaly; B Sandor; A Lubics; E Laszlo; J Farkas; A Matkovits; R Brubel; H Hashimoto; A Ferencz; A Vincze; Z Helyes; L Welke; A Lakatos; A Tamas
Journal:  J Mol Neurosci       Date:  2012-04-14       Impact factor: 3.444

Review 9.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

10.  Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.

Authors:  Andrea Tamas; Andras Javorhazy; Dora Reglodi; Donat Peter Sarlos; Daniel Banyai; David Semjen; Jozsef Nemeth; Beata Lelesz; Daniel Balazs Fulop; Zalan Szanto
Journal:  J Mol Neurosci       Date:  2015-10-10       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.